Navigation Links
SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results
Date:5/1/2009

ASSETS Current Assets Cash and cash equivalents $4,713,909 $6,363,243 Accounts receivable 163,364 177,253 Interest and other receivables 1,225 1,157 Prepaid expenses 219,953 286,539 Total current assets 5,098,451 6,828,192 Property and Equipment - net of accumulated depreciation of $1,251,100 and $1,289,844, respectively 801,703 790,947 Intangible assets - net of accumulated amortization of $452,935 and $465,724, respectively 495,052 557,639 Restricted cash 473,711 473,711 $6,868,917 $8,650,489 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities Accounts payable $247,332 $238,701 Accrued liabilities 473,209 668,694 Current portion of term loan 89,917 87,850 Total current liabilities 810,458 995,245 Long-term portion of term loan - 23,269 Deferred rent 301,517 310,010 Total liabilities 1,111,975 1,328,524 Commitments and Contingencies Stockholders' Equity Preferred stock, authorized 5,000,000 shares, $.01 par value, none issued or outstanding - - Common stock, authorized 100,000,000 shares, $.001 par value 41,098,270 and 41,130,270 issued and outstanding as of March 31, 2009 and December 31, 2008, respectively 41,098
'/>"/>
SOURCE SCOLR Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. SCOLR Pharma, Inc. Schedules First Quarter 2009 Financial Results Conference Call for May 1, 2009 at 11:30 A.M. Eastern
2. SCOLR Pharma, Inc. Announces Engagement of HealthPro as Financial Advisor
3. SCOLR Pharma, Inc. Schedules Fourth Quarter 2008 Financial Results Conference Call for March 11, 2009 at 11:30 A.M. Eastern
4. SCOLR Pharma, Inc. Announces Appointment of Bruce S. Morra, Ph.D., as President & CEO
5. SCOLR Pharma, Inc. Announces Resignation of CEO Daniel O. Wilds
6. SCOLR Pharma, Inc. Announces Positive Top-Line Results From Pivotal Clinical Trial Evaluating Efficacy of Extended-Release Ibuprofen
7. SCOLR Pharma, Inc. Schedules Third Quarter 2008 Financial Results Conference Call for November 7, 2008 at 11:30 A.M. Eastern
8. SCOLR Pharma, Inc. Submits Abbreviated New Drug Application for a 12-hour CDT-based Pseudoephedrine Formulation
9. Sinobiopharma, Inc. Signs Sales Contract for Flagship Project
10. China Biopharma, Inc. Issues Corporate Information Update
11. Why Do Drugs Cost So Much? and why are we so darn sick?: New Book Reveals Inner Workings of Big Pharma, Asks Hard Questions About Our Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... ... 29, 2015 , ... Hamstring strain have not ... tissue manipulation. Platelet rich plasma injections also have mixed results. Building core ... treatment outcomes. This localized treatment seems to address the symptoms and does offer ...
(Date:8/28/2015)... ... August 28, 2015 , ... Joining a growing number of ... transitioned management companies to partner with Wound Care Advantage (WCA) to utilize the ... , Transitioning wound care management providers can be a complex undertaking. WCA ...
(Date:8/28/2015)... ... August 28, 2015 , ... An article published ... maker Paul LaRocco has gone through to open a pizzeria in Westchester. Mr. LaRocco ... tends to take several months, but the current process, having already gone on for ...
(Date:8/28/2015)... ... 28, 2015 , ... As reported by Medical Daily on August 22 ... results that last for two years, the longest of any cellulite reduction system currently ... for a long-lasting, effective solution for their cellulite, according to Dr. Robert Weiss, director ...
(Date:8/28/2015)... ... August 28, 2015 , ... Saint Petersburg, FL —Pocket Protein™, ... fat, carbs, sugar, gluten, lactose or caffeine in a convenient 2 oz. pouch ... CPG Editor’s Choice Awards. , Five consumer packaged goods (CPG) products were selected ...
Breaking Medicine News(10 mins):Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4Health News:Article on Building Approval Process for LA Business Highlights the Need for a Bridge Between Businesses and City Officials, says Fire Protection Group Inc. 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3
... Reporter , THURSDAY, June 24 (HealthDay News) -- Scientists have succeeded ... of an old one in rats. The researchers, reporting ... day to replicate the feat in humans, giving hope to the ... (COPD) and perhaps even lung cancer. But that could take ...
... trial of a novel radioactive compound readily and safely ... volunteers on brain scans and opens the doors to ... their own radioactive compounds. The results, reported by a ... Nuclear Medicine, could lead to better ways to ...
... study done by researchers at Wake Forest University Baptist Medical ... mean a hospital stay there is another option for ... cases, allows the patient to return home the same day. ... States visit the emergency department (ED) because they are experiencing ...
... 2010) A team of researchers led by NewYork-Presbyterian ... predict post-stroke recovery of language by measuring the initial ... important implications for stroke survivors and their families, as ... are reported online in the journal Stroke . ...
... a world-leading publisher of scientific, technical and medical information ... a pilot project to evaluate the process by which ... VIVO instances. The pilot project, carried out by the ... a Scopus Custom Data dataset and will serve as ...
... College London, is to be the first ever recipient of ... contributions he has made to the field of movement disorders ... his delivery of the inaugural Lord Brain Memorial Lecture; "Brainwashed ... School on June 24, 2010. The Lord Brain Memorial ...
Cached Medicine News:Health News:Scientists Fashion New Lung for Rats 2Health News:Scientists Fashion New Lung for Rats 3Health News:Novel radiotracer shines new light on the brains of Alzheimer's disease patients 2Health News:Cardiac MRI in the ER cuts costs, hospital admissions for chest pain patients 2Health News:Cardiac MRI in the ER cuts costs, hospital admissions for chest pain patients 3Health News:New metric predicts language recovery following stroke 2Health News:VIVO utilizing Scopus custom data 2Health News:Lord Brain Memorial Lecture is launched in recognizing outstanding contribution to neuroscience 2
(Date:8/28/2015)... , Aug. 28, 2015 Perrigo Company ... on the Mylan N.V. ("Mylan") (NASDAQ: MYL ) ... Perrigo. "Our views of Mylan,s offer to ... be, based on our Board,s careful reflection of the ... on the limited choices that Mylan has allowed its ...
(Date:8/28/2015)... , FARUM, Denmark and ... On July 31, 2015 the US Food and Drug ... treatment of Major Depressive Disorder in adult patients who have ... the current episode. TMS is a non-invasive technique for stimulating ... patients suffering from Major Depressive Disorder. The procedure has been ...
(Date:8/28/2015)... , Aug. 28, 2015 ... and Dr. Ra from Biostar , Published in ... 30% increase of lifespan through multiple IV administration of ... vitality, and life expectancy found , Commercialization within ... have determined the possibility that adult mesenchymal stem cells ...
Breaking Medicine Technology:Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2
... Therapeutics,(OTC Bulletin Board: ECTE) today announced positive ... Transdermal Continuous Glucose Monitoring (tCGM),System in patients ... Echo,s non-invasive,Symphony tCGM System consists of its ... Prelude(TM) SkinPrep System, which,incorporates leading-edge, needle-free skin ...
... TRIANGLE PARK, N.C., July 27 Timothy Mastro,MD, ... on August 1st,as Senior Director of Research, will ... for HIV prevention at the,International AIDS Conference in ... Prophylaxis: Current,and Planned Trials," will examine ongoing and ...
Cached Medicine Technology:Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes 2Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes 3Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes 4HIV Prevention Expert Dr. Timothy Mastro Speaks on Future of Pre-Exposure Prophylaxis at International AIDS Conference 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: